Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link.

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• The mevalonate pathway is essential for cholesterol synthesis and protein prenylation, critical for cellular processes.
• Deregulation of this pathway and reduced protein prenylation are linked to mitochondrial dysfunction and impaired autophagy.
• Mevalonate Kinase Deficiency (MKD) is an autoinflammatory disease caused by MVK gene mutations affecting this pathway.

Purpose of the Study:

• To analyze the correlation between mevalonate pathway defects, mitochondrial dysfunction, and defective autophagy.
• To explore the role of these mechanisms in the pathogenesis of Mevalonate Kinase Deficiency.
• To clarify the current pathogenetic hypotheses underlying MKD.

Main Methods:

• Literature review focusing on the mevalonate pathway, protein prenylation, mitochondrial function, and autophagy.
• Analysis of existing data on Mevalonate Kinase Deficiency patients and MVK gene mutations.
• Correlation analysis between biochemical pathway defects and clinical manifestations.

Main Results:

• Mevalonate pathway blockade leads to diminished protein prenylation and mitochondrial dysfunction.
• Defective autophagy, potentially caused by reduced protein prenylation, contributes to inflammasome activation and cell death.
• MKD patients exhibit increased inflammation and reduced protein prenylation levels.

Conclusions:

• Defective autophagy's failure to clear damaged mitochondria may drive cell death in MKD.
• The interplay between mevalonate pathway defects, mitochondrial dysfunction, and autophagy is a key pathogenetic mechanism in MKD.
• Understanding these links provides a basis for future therapeutic strategies for MKD.